With Santosh Chari
The Supreme Court of Canada, in Teva Canada Ltd. v. Pfizer Canada Inc. held Pfizer's patent for the use of sildenafil, commercially known as Viagra®, void, thereby allowing Teva to market a generic version of the drug prior to expiry of the patent in 2014.